One of 57 (1.7%) bone osteosarcomas not treated with neo-adjuvant chemotherapy, and one radiation-induced osteosarcoma of 19 (5.3%) bone osteosarcomas on which treatment information was not available also revealed FGFR1 amplification. The gene discussed is FGFR1; the disease is osteosarcoma.